Detalhe da pesquisa
1.
The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making.
BMC Med
; 21(1): 229, 2023 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37400797
2.
The CAPACITI Decision-Support Tool for National Immunization Programs.
Value Health
; 24(8): 1150-1157, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34372981
3.
Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap.
Sex Health
; 16(5): 426-432, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31476278
4.
Critical Needs in Advancing Shigella Vaccines for Global Health.
J Infect Dis
; 225(9): 1500-1503, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558631
5.
Facilitating the development of urgently required combination vaccines.
Lancet Glob Health
; 12(6): e1059-e1067, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38636529
6.
A Practical Guide to Full Value of Vaccine Assessments.
Vaccines (Basel)
; 12(2)2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400184
7.
A review of potential use cases for measles-rubella, measles-mumps-rubella, and typhoid-conjugate vaccines presented on microarray patches.
Vaccine
; 42(6): 1230-1246, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326130
8.
The Full Value of Vaccine Assessments Concept-Current Opportunities and Recommendations.
Vaccines (Basel)
; 12(4)2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38675817
9.
Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting report.
Vaccine
; 41(49): 7307-7312, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37949751
10.
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021.
Vaccine
; 41(11): 1799-1807, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803897
11.
Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening.
Vaccine
; 41(16): 2634-2644, 2023 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932030
12.
Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification.
Front Public Health
; 11: 1165110, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377552
13.
Vaccine value profile for Shigella.
Vaccine
; 41 Suppl 2: S76-S94, 2023 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827969
14.
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.
Expert Opin Drug Deliv
; 20(3): 315-322, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36649573
15.
Vaccine value profile for enterotoxigenic Escherichia coli (ETEC).
Vaccine
; 41 Suppl 2: S95-S113, 2023 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951695
16.
Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries.
Lancet Glob Health
; 11(11): e1819-e1826, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858591
17.
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.
Lancet Glob Health
; 11(4): e546-e555, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36925175
18.
What Drives the Value of a Shigella Vaccine?
Vaccines (Basel)
; 10(2)2022 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35214740
19.
Accelerating access for all through research and innovation in immunization: Recommendations from Strategic Priority 7 of the Immunization Agenda 2030.
Vaccine
; 2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529593
20.
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges.
Front Public Health
; 10: 809675, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35309224